September 4, 2011 |
Reporting from Atlanta -- Hong-Chih Kuo said baseball is fun for him again — and so long as his elbow holds up, the former All-Star reliever intends to pitch again next season. "I'll try to pitch," Kuo said. This wasn't always a given. In a season in which he landed on the disabled list because of an anxiety disorder and performed erratically, there were times when Kuo was noncommittal about his future. Kuo, whose earned-run average was 12.46 as recently as July 31, has looked like the Kuo of old in recent weeks.
CALIFORNIA | LOCAL
September 6, 2000
An anxiety clinic has opened at Cal State Northridge to serve the community and provide hands-on training for psychology students. The clinic is staffed by six to eight graduate students in the Psychology Department's master's program in clinical health. It plans to serve up to 50 clients a semester. The students will be under the supervision of professor Ronald Doctor, a clinical psychologist who has worked in the area of anxiety disorders for 30 years.
February 25, 2011 |
Post-traumatic stress disorder, or PTSD, is a lingering psychological response to a major traumatic event. And researchers studying the condition now have a clue about its development. Hint: Women and men are different. Their study, conducted in part at Emory University in Atlanta, was published Wednesday in the journal Nature. Researchers tested 64 people who had experienced significant trauma in noncombat settings. In women but not men, they found a link between PTSD and high levels of a hormone called pituitary adenylate cyclase-activating polypeptide produced in response to stress.
August 5, 2002 |
Frightening or painful memories may be calmed or even erased by marijuana-like chemicals produced in the brain, according to a study of mice chronicled in Thursday's issue of Nature. Mice bred to be unresponsive to the chemicals, called cannabinoids, couldn't control their reaction when they heard a reminder linked to pain. Normal mice eventually stopped flinching at the reminder.
May 14, 2001 |
Discovery Health Channel Begins May 20, 7 p.m. * Mental illness strikes one in every five Americans in any given year. Yet despite the high incidence, serious mental disorders are still profoundly stigmatized. "Fires of the Mind," a well-made four-segment series that premieres Sunday on the Discovery Health Channel, attempts to dispel some of the frightening myths that cloud the public's perception of four severe mental conditions: schizophrenia, depression, autism and anxiety disorders.
January 10, 2005 |
Shy children tend to have muted reactions to joy or anger in the facial expressions of others, inhibitions that may lead to the anxieties many experience later in life, researchers have found. Shy children seem to miss emotional cues that are "socially relevant," wrote study author Marco Battaglia of the San Raffaele Scientific Institute in Milan, Italy.
October 20, 1997 |
Longtime users of hormone replacement therapy had a higher risk of localized, but not metastatic, breast cancer, according to an expansive report published in the Oct. 11 issue of the Lancet. British researchers reanalyzed 51 epidemiological studies of 52,705 women with breast cancer and more than 108,000 women free of the disease to better pinpoint the risks associated with use of hormones.
CALIFORNIA | LOCAL
May 2, 1995 |
Those who suffer from phobias, panic attacks and just free-floating anxiety can get free advice Wednesday when UCI Medical Center in Orange hosts National Anxiety Disorders Screening Day. "The screening is for anyone who thinks that they might be suffering from an anxiety disorder," explained Marsha K. Stein, a psychiatrist at the medical center's neuropsychiatric unit. Anxiety covers a broad range of symptoms, Stein said.
December 28, 1999
Interneuron Pharmaceuticals Inc. said it has licensed to Warner-Lambert Co. worldwide rights to its experimental drug pagoclone, for treating panic and anxiety disorders. The news pushed shares of Interneuron to a new 52-week high of $8.75 before edging back down to close at $6.88, up $2.38, on Nasdaq. Under the agreement, Warner-Lambert will pay Lexington, Mass.-based Interneuron as much as $73.75 million in an upfront payment and milestones.